CClinicalTrials.gg
RecruitingNCT07473583TAPPHCO3Updated Mar 16, 2026

Pneumoperitoneum Duration and Bicarbonate Changes in Laparoscopic Hernia Surgery

An observational study in Hernia, Inguinal and Inguinal Hernia, sponsored by Haseki Training and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-16.

Sponsored by Haseki Training and Research Hospital · Observational

From the registry’s dates

  • Primary completion was expected by Apr 2026, 6 months ago, but the record still lists the study as recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this observational study is to learn how the length of pneumoperitoneum during laparoscopic inguinal hernia surgery may affect changes in blood bicarbonate levels. Pneumoperitoneum is the use of carbon dioxide gas to create space inside the abdomen during laparoscopic surgery.

The main question this study aims to answer is whether a longer pneumoperitoneum time is associated with changes in blood bicarbonate levels after surgery.

Participants are adults undergoing laparoscopic inguinal hernia repair as part of their routine medical care. Researchers will measure blood gas values, including bicarbonate levels, before surgery and again two hours after surgery. The change in bicarbonate levels will be compared with the duration of pneumoperitoneum during the operation.

The results of this study may help improve the understanding of metabolic changes that occur during laparoscopic surgery.

Read the detailed description

Carbon dioxide pneumoperitoneum is routinely used during laparoscopic surgery to provide adequate visualization and working space. However, absorption of carbon dioxide and increased intra-abdominal pressure may influence acid-base balance during the perioperative period. These physiological changes may be reflected in blood gas parameters such as pH, partial pressure of carbon dioxide (pCO2), and serum bicarbonate levels.

This prospective observational study aims to evaluate the relationship between pneumoperitoneum duration and perioperative changes in serum bicarbonate levels in patients undergoing laparoscopic inguinal hernia repair using the transabdominal preperitoneal (TAPP) technique.

Adult patients undergoing elective laparoscopic inguinal hernia repair will be included in the study. Blood gas measurements will be obtained before surgery and at the second postoperative hour. Serum bicarbonate levels will be recorded, and the difference between preoperative and postoperative measurements (ΔHCO3-) will be calculated.

The primary outcome of the study is the change in serum bicarbonate levels between the preoperative and postoperative second-hour measurements. Secondary outcomes include postoperative pain scores, postoperative acid-base parameters such as pH and pCO2, and early postoperative complications within the first 24 hours.

Pneumoperitoneum duration will be recorded intraoperatively and analyzed for its association with perioperative metabolic changes. The findings of this study may contribute to a better understanding of metabolic alterations occurring during laparoscopic surgery and their potential clinical implications.

02

Conditions studied

  • Hernia, Inguinal
  • Inguinal Hernia

Keywords

  • Pneumoperitoneum
  • Laparoscopic Inguinal Hernia Repair
  • Serum Bicarbonate
  • Blood Gas Analysis
  • TAPP Technique
03

In context

Hernia, Inguinal

549 studies on the registry are indexed under Hernia, Inguinal; 74 are open to participants now.

This study's planned enrollment of 100 is below the median of 150 across 133 observational studies indexed under Hernia, Inguinal.

Browse Hernia, Inguinal studies →

Lead sponsor

Haseki Training and Research Hospital is the lead sponsor of 75 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients undergoing laparoscopic inguinal hernia repair (TAPP) at Haseki Training and Research Hospital will be included. Perioperative pneumoperitoneum duration and serum bicarbonate changes will be analyzed using blood gas measurements obtained preoperatively and at the second postoperative hour.

Inclusion criteria

  • Age ≥18 years
  • Patients undergoing laparoscopic inguinal hernia repair using the TAPP technique
  • Ability to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Severe cardiovascular disease
  • Renal insufficiency
  • Patients requiring additional intra-abdominal surgical procedures
  • Strangulated inguinal hernia requiring bowel resection
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Laparoscopic Inguinal Hernia Patients

    Adult patients undergoing laparoscopic inguinal hernia repair (TAPP). Pneumoperitoneum duration and perioperative serum bicarbonate changes will be analyzed using blood gas measurements obtained preoperatively and at the second postoperative hour.

    Procedure: Laparoscopic Inguinal Hernia Repair (TAPP)

Interventions

  • ProcedureLaparoscopic Inguinal Hernia Repair (TAPP)

    Standard laparoscopic inguinal hernia repair performed using the transabdominal preperitoneal (TAPP) technique as part of routine clinical care. Pneumoperitoneum duration during the procedure will be recorded for analysis.

06

What researchers measure

Primary outcomes

  1. Change in Serum Bicarbonate Level

    Difference between preoperative and postoperative second-hour serum bicarbonate levels measured by blood gas analysis in patients undergoing laparoscopic inguinal hernia repair. Unit of Measure: mmol/L

    Time frame: Preoperative to postoperative 2 hours

Secondary outcomes

  1. Postoperative Pain Score

    Postoperative pain intensity measured using the Visual Analog Scale (VAS). The scale ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores represent greater pain severity. Unit of Measure: VAS score (0-10)

    Time frame: Within 24 hours after surgery

  2. Change in Arterial Blood pH

    Change in arterial blood pH measured during pneumoperitoneum. Unit of Measure: pH

    Time frame: Preoperative to postoperative 2 hours

  3. Early Postoperative Complications

    Early postoperative complications occurring within the first 24 hours after laparoscopic inguinal hernia repair.

    Time frame: Within 24 hours

  4. Change in Arterial Partial Pressure of Carbon Dioxide

    Change in arterial PaCO₂ levels measured intraoperatively. Unit of Measure: mmHg

    Time frame: Preoperative to postoperative 2 hours

07

Study locations

1 of 1 sites recruiting
  • Haseki Training and Research Hospital
    Istanbul, 34265, Turkey (Türkiye)
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared due to institutional data protection policies and patient confidentiality requirements. Only aggregated and anonymized data will be reported in scientific publications.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07473583
Lead sponsor
Haseki Training and Research Hospital
Responsible party
Sponsor
First posted
Mar 16, 2026
Start date
Mar 10, 2026 (estimated)
Primary completion
Apr 2026 (estimated)
Completion
May 2026 (estimated)
Last update
Mar 16, 2026

Study contacts

Osman Sibic, MD
Contact
osmansibic@gmail.com
+90 534 617 72 53
Bahar Canbay Torun, MD
Contact
baharcanbay@gmail.com
+90 505 389 0489
Muzaffer Akinci, MD
principal investigator · Haseki Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion